Do Short- and Long-Term Results of Left Atrium Appendage Closure Differ Between Men and Women?

Left atrium appendage closure (LAAC) is a major strategy to prevent stroke in patients with nonvalvular atrial fibrillation (AF).

cierre de orejuela de aurícula izquierda

LAAC registries to date show that women present twice the risk for major events and higher rates of in-hospital complications and hospital re-hospitalization at 30 days when compared with men. However, long-term results according to sex are not available.

The aim of this study was to perform a post hoc analysis of the randomized AMULET IDE study to examine the short- and long-term difference in LAAC outcomes between men and women.

The following outcomes were assessed: in-hospital complications, peri-device leak at 45 days, device-related thrombus at 18 months, and long-term events (death, thromboembolism, and bleeding).

Out of 1833 patients, Amulet devices were implanted in 917, while 916 received Watchman devices. Of these, 40% were women.

Read also: Left Atrial Appendage Closure Is a Valid Option.

A demographic analysis established that the men were younger, had higher rates of permanent and persistent AF, and a history of cardiovascular or cerebrovascular procedures. They also had lower ejection fraction and a more history of acute myocardial infarction, diabetes, vascular disease, and heart failure.

Procedural success was about 97%, with no differences between sexes. The in-hospital event rate was higher in women (4.4% vs. 1.9%; p < 0.01), driven by the rates for major bleeding (3.7% vs. 1.0%; p < 0.01) and pericardial effusion requiring intervention (2.0% vs. 0.5%; p < 0.01).

The rates of leak and device-related thrombus were similar between men and women (18.3% vs 18.9% [p = 0.78] and 3.3% vs. 5.0% [p = 0.10], respectively).

Read also: TCT 2022 | AMULET IDE: Events at 3 Years Using the AMULET Appendage Closure Device.

When long-term outcomes were analyzed, there were no differences between sexes in the rates of stroke or systemic embolism, transient ischemic attack, hemorrhagic stroke, major bleeding, cardiovascular death, and all-cause mortality.

Conclusion

The long-term outcomes of patients undergoing LAAC are similar between men and women, despite the increased rate of in-hospital complications observed in women due to higher rates of major bleeding and pericardial effusion requiring intervention.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original title: Sex Differences in Safety and Effectiveness of Left Atrial Appendage Occlusion Insights From the Amulet IDE Trial.

Reference: Mohamad Alkhouli, MD et al J Am Coll Cardiol Intv 2022.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....